ArticleBritish journal of haematology2014

The bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach.

Mariela Sivina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.